Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGNX vs NOVT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGNX Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

CGNX Overall Winner 6-Pillar Tally: CGNX 5 – 1 NOVT Matrix Metrics: CGNX 8 – 2 NOVT

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over Novanta Inc. (NOVT) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas NOVT carries 43.5/100 (HOLD) at $115.60 (8.4x Forward P/E, 11.8% operating margin).

  • Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile NOVT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGNX vs NOVT
CGNX NASDAQ Head-to-Head Winner
Cognex Corp
Industrial Instruments For Measurement, Display, And Control
$48.06
-3.9% 1D
Market Cap $8.5B
TTM Revenue $1.13B
Forward P/E 24.7x
Beta / 30D Vol 2.19β · 65% Vol
Unified Composite Score
59.5 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 36
RSI-14: 35.9 · SMA20: $53.86 · SMA50: $57.80
NOVT NASDAQ
Novanta Inc. Common Stock
Miscellaneous Electrical Machinery, Equipment & Supplies
$115.60
-2.76% 1D
Market Cap $4.4B
TTM Revenue $1.09B
Forward P/E 8.4x
Beta / 30D Vol 2.00β · 78% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 29.0 Fund 48.0 Flow 70.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 34
RSI-14: 33.7 · SMA20: $137.20 · SMA50: $139.61

6-Pillar Scorecard Institutional Category Breakdown (CGNX 5 – 1 NOVT)

Columns: Metric · CGNX · NOVT
1. Valuation Multiples NOVT
Forward P/E 24.7x 8.4x
Trailing P/E 35.5x 87.9x
PEG Ratio 2.71x 2.11x
EV / Revenue 7.0x 4.7x
2. Growth & Scale CGNX
Revenue Growth (YoY) +13.2% +23.1%
Earnings Growth (YoY) +400.0% -84.0%
TTM Revenue (USD) $1.13B $1.09B
Market Cap $8.5B $4.4B
3. Profitability & Quality CGNX
Gross Margin 69.7% 44.5%
Operating Margin 25.0% 11.8%
Net Profit Margin 21.5% 4.9%
Return on Equity (ROE) 15.1% 4.4%
4. Balance Sheet & Cash Flow CGNX
Cash Generation (TTM) $286M $140M
Cash Flow Margin 25.4% 12.9%
Net Cash / Leverage $624M Net Cash $744M Net Debt (0.55x D/E)
Dividend Yield 0.66% None (0.00%)
5. Options & Positioning CGNX
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 53.5% (16th %ile) 54.3% (12th %ile)
Put/Call OI Skew 1.96x (Put-Skewed) 99.57x (Put-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat CGNX
OpEx & R&D Intensity 44.7% of Rev ($503M) 32.7% of Rev ($355M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGNX (8) vs NOVT (2)
Institutional Metric CGNX NOVT Criterion Row Edge
Market Capitalization
Scale
$8.5B $4.4B Larger Scale CGNX
Trailing P/E Ratio
Valuation
35.5x 87.9x Lower Multiple CGNX
Forward P/E Ratio
Valuation
24.7x 8.4x Lower Multiple NOVT
Revenue Growth (YoY)
Growth
+13.2% +23.1% Higher Growth NOVT
Operating Margin (TTM)
Profitability
25.0% 11.8% Higher Margin CGNX
Net Profit Margin
Profitability
21.5% 4.9% Higher Margin CGNX
Return on Equity (ROE)
Capital Efficiency
15.1% 4.4% Higher ROE CGNX
52-Week Range Position
Momentum
35% ($35–$73) 22% ($98–$176) Stronger Trend CGNX
Beta / 30D Volatility
Risk Regime
2.19β · 65% Vol 2.00β · 78% Vol Lower Realized Risk CGNX
Unified Institutional Score
Composite Signal
59.5 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite CGNX
Trailing 12M Revenue (USD)
Operating Scale
$1.13B $1.09B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.7% 44.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.71x PEG · 7.0x EV/Rev 2.11x PEG · 4.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$286M ($624M Net Cash) $140M ($744M Net Debt (0.55x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NOVT +0.74 pp
CGNX: -10.98% · NOVT: -10.24%
3M Horizon CGNX +2.21 pp
CGNX: -24.21% · NOVT: -26.42%
6M Horizon CGNX +1.21 pp
CGNX: -22.37% · NOVT: -23.58%
1Y Horizon CGNX +23.43 pp
CGNX: +29.72% · NOVT: +6.29%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CGNX Revenue NOVT Revenue CGNX Op. Margin NOVT Op. Margin Margin Leader
FY2018 $810M $610M 27.4% 11.6% CGNX
FY2019 $730M $630M 19.7% 8.8% CGNX
FY2020 $810M $590M 21.0% 9.5% CGNX
FY2021 $1.04B $710M 30.4% 9.1% CGNX
FY2022 $1.01B $860M 24.5% 12.0% CGNX
FY2023 $840M $880M 15.6% 12.5% CGNX
FY2024 $910M $950M 12.6% 11.6% CGNX
FY2025 $990M $980M 16.3% 9.6% CGNX

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGNX BREAKDOWN
120d in phase · OBV ACCUMULATION
Current IV 53.5%
IV Percentile 16th %ile
Put/Call OI Skew 1.96x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact CGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NOVT BREAKDOWN
115d in phase · OBV DISTRIBUTION
Current IV 54.3%
IV Percentile 12th %ile
Put/Call OI Skew 99.57x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact NOVT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGNX Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.5B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($503M)
90D Engineering Disclosures 0 Published
NOVT Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $4.4B market capitalization and 11.8% operating margin.
OpEx & R&D Reinvestment 32.7% of Rev ($355M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
Analog Devices Texas Instruments STMicroelectronics Infineon Technologies

Investor FAQ CGNX vs NOVT Key Questions & Quantitative Answers

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over Novanta Inc. (NOVT) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas NOVT carries 43.5/100 (HOLD) at $115.60 (8.4x Forward P/E, 11.8% operating margin). Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile NOVT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CGNX leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with NOVT at +23.1% YoY revenue growth and -84.0% YoY earnings growth on $1.09B TTM revenue (44.5% gross margin, 11.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CGNX cumulative revenue shifted +22.2% while NOVT shifted +60.7%. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 32.7% of Rev ($355M) (0 disclosures) for NOVT.

NOVT screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas NOVT trades at 8.4x Forward P/E, 87.9x Trailing P/E, 2.11x PEG, and 4.7x EV/Revenue (12.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus NOVT (4.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, NOVT carries 54.3% implied volatility (12th %ile, Compressed (<25th %ile)), a 99.57x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.00β · 78% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.